-
EP4088723
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4088723
| EP4088723 - CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 14.10.2022 Database last updated on 29.07.2024 | |
| Former | The international publication has been made Status updated on 16.07.2021 | Most recent event Tooltip | 29.01.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Chengdu Baiyu Pharmaceutical Co., Ltd. 10th Floor, Building B7 Tianfu Life Science Park No. 88 Keyuan South Road High-Tech Zone Chengdu, Sichuan 611130 / CN | [2022/46] | Inventor(s) | 01 /
XU, Xuezhen 10th Floor, Building B7, Tianfu Life Science Park No.88 Keyuan South Road, High-Tech Zone Chengdu, Sichuan 611130 / CN | 02 /
ZHANG, Jing 10th Floor, Building B7, Tianfu Life Science Park No.88 Keyuan South Road, High-Tech Zone Chengdu, Sichuan 611130 / CN | 03 /
WEI, Yonggang 10th Floor, Building B7, Tianfu Life Science Park No.88 Keyuan South Road, High-Tech Zone Chengdu, Sichuan 611130 / CN | 04 /
CHU, Hongzhu 10th Floor, Building B7, Tianfu Life Science Park No.88 Keyuan South Road, High-Tech Zone Chengdu, Sichuan 611130 / CN | 05 /
ZHAO, Fuqiang 10th Floor, Building B7, Tianfu Life Science Park No.88 Keyuan South Road, High-Tech Zone Chengdu, Sichuan 611130 / CN | 06 /
SU, Guizhuan 10th Floor, Building B7, Tianfu Life Science Park No.88 Keyuan South Road, High-Tech Zone Chengdu, Sichuan 611130 / CN | 07 /
WANG, Meiwei 10th Floor, Building B7, Tianfu Life Science Park No.88 Keyuan South Road, High-Tech Zone Chengdu, Sichuan 611130 / CN | 08 /
SUN, Yi 10th Floor, Building B7, Tianfu Life Science Park No.88 Keyuan South Road, High-Tech Zone Chengdu, Sichuan 611130 / CN | [2022/46] | Representative(s) | Kador & Partner Part mbB Corneliusstraße 15 80469 München / DE | [N/P] |
| Former [2022/46] | Kador & Partner PartG mbB Corneliusstraße 15 80469 München / DE | Application number, filing date | 21738886.7 | 07.01.2021 | [2022/46] | WO2021CN70728 | Priority number, date | CN20201016851 | 08.01.2020 Original published format: CN202010016851 | [2022/46] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021139739 | Date: | 15.07.2021 | Language: | ZH | [2021/28] | Type: | A1 Application with search report | No.: | EP4088723 | Date: | 16.11.2022 | Language: | EN | [2022/46] | Search report(s) | International search report - published on: | CN | 15.07.2021 | (Supplementary) European search report - dispatched on: | EP | 22.01.2024 | Classification | IPC: | A61K31/662, A61K31/664, C07D403/04, C07C39/19, C07F9/44, A61P25/04, A61K45/06, A61P9/10, A61P9/12, A61P25/00, A61P25/06, A61P25/08, A61P25/14, A61P25/16, A61P25/28, A61P25/22, A61P29/00, C07B59/00 | [2024/08] | CPC: |
C07F9/443 (EP);
C07F9/36 (CN,US);
A61K31/365 (CN);
A61K31/664 (CN);
A61K45/06 (EP);
A61P19/02 (EP,CN);
A61P25/00 (EP,CN);
A61P25/02 (EP,CN);
A61P25/04 (EP,CN);
A61P25/06 (EP,CN);
A61P25/08 (EP,CN);
A61P25/14 (EP,CN);
A61P25/16 (EP,CN);
A61P25/22 (EP,CN);
A61P25/28 (EP,CN);
A61P25/32 (EP,CN);
A61P29/00 (EP,CN);
A61P35/00 (EP,CN);
| C-Set: |
A61K31/365, A61K2300/00 (CN);
A61K31/664, A61K2300/00 (CN) |
| Former IPC [2022/46] | A61K31/662, A61K31/664, C07D403/04, C07C39/19, C07D401/10, A61P25/04, A61K31/352 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/46] | Title | German: | CANNABIDIOLDERIVAT, VERFAHREN ZU SEINER HERSTELLUNG UND MEDIZINISCHE VERWENDUNG DAVON | [2022/46] | English: | CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | [2022/46] | French: | DÉRIVÉ CANNABIDIOL ET SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION MÉDICALE | [2022/46] | Entry into regional phase | 07.07.2022 | Translation filed | 07.07.2022 | National basic fee paid | 07.07.2022 | Search fee paid | 07.07.2022 | Designation fee(s) paid | 07.07.2022 | Examination fee paid | Examination procedure | 07.07.2022 | Amendment by applicant (claims and/or description) | 07.07.2022 | Examination requested [2022/46] | Fees paid | Renewal fee | 30.01.2023 | Renewal fee patent year 03 | 29.01.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US2005020544 (GARZON AARON [IL], et al) [A] 1-8 * compound U ** abstract * | International search | [A]WO2004016254 (IMMUGEN PHARMACEUTICALS INC [US], et al) [A] 1-7 * entire document *; | [A]US2015258040 (LYNCH MARY [CA], et al) [A] 1-7* entire document *; | [A]WO2015184127 (INSYS PHARMA INC [US]) [A] 1-7 * entire document *; | [A]WO2015191728 (POVIVA TEA LLC [US]) [A] 1-7 * entire document *; | [A]WO2017132526 (UNIV MISSISSIPPI [US]) [A] 1-7 * entire document *; | [A]WO2018096504 (KALYTERA THERAPEUTICS INC [US]) [A] 1-7 * abstract ; claims 1, 30 * |